Hartford Investment Management Co. Decreases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Hartford Investment Management Co. trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 2.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 62,279 shares of the healthcare conglomerate’s stock after selling 1,349 shares during the quarter. UnitedHealth Group accounts for about 1.2% of Hartford Investment Management Co.’s holdings, making the stock its 12th biggest holding. Hartford Investment Management Co.’s holdings in UnitedHealth Group were worth $32,788,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Robbins Farley bought a new stake in UnitedHealth Group during the 3rd quarter valued at $25,000. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group during the fourth quarter valued at about $26,000. CGC Financial Services LLC grew its stake in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the last quarter. NewSquare Capital LLC raised its position in UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares during the last quarter. Finally, LFA Lugano Financial Advisors SA grew its position in shares of UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. HSBC reaffirmed a “reduce” rating and issued a $480.00 price target (down previously from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. Bank of America reaffirmed a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Piper Sandler cut their price objective on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 17th. Oppenheimer reissued an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Finally, Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $579.33.

Check Out Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Stock Up 0.7 %

UNH stock traded up $3.27 during midday trading on Wednesday, hitting $461.41. The company’s stock had a trading volume of 2,132,790 shares, compared to its average volume of 4,168,840. The company has a market cap of $425.39 billion, a PE ratio of 19.29, a P/E/G ratio of 1.33 and a beta of 0.54. The firm’s 50-day moving average is $500.89 and its 200-day moving average is $518.93. UnitedHealth Group Incorporated has a 12 month low of $445.68 and a 12 month high of $554.70. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, topping the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. During the same period last year, the company earned $5.34 EPS. UnitedHealth Group’s revenue for the quarter was up 14.1% on a year-over-year basis. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.63%. UnitedHealth Group’s payout ratio is 31.54%.

Insider Buying and Selling

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.